Cambridge Cognition joins Imperial College-led NHS study for Alzheimer's diagnosis

Neuroscience technology company Cambridge Cognition will participate in the BEAD-PC study, led by Imperial College London. The study will evaluate combining CANTAB digital cognitive assessments with blood-based biomarkers for earlier Alzheimer's diagnosis in primary care.